This comprehensive guide on FDA inspections is an essential resource for clinical researchers, investigators, and research site staff involved in FDA-regulated clinical trials. It covers everything you need to know about FDA oversight , why and how inspections are conducted, and the types of inspections you may face, including routine, for-cause, and pre-approval visits. Learn how to prepare effectively before the FDA arrives by maintaining inspection-ready documentation, creating a culture of compliance, and training your team. The book details what happens during inspections, common questions asked by FDA inspectors , and how to provide ideal answers that demonstrate regulatory compliance. Explore real-world examples of common inspection findings such as inadequate informed consent, protocol deviations, and investigational product accountability issues. Understand the serious consequences of noncompliance, including FDA Form 483 observations , Warning Letters, data rejection, and disqualification proceedings. The guide also offers practical advice on responding to FDA findings with strong corrective and preventive action plans (CAPAs) and timelines. Stay ahead with chapters on digital tools and the evolving landscape of FDA e-inspections , as well as considerations for global research sites inspected outside the U.S. Bonus case studies of actual FDA Warning Letters provide valuable lessons to avoid pitfalls and maintain study integrity. Perfect for clinical research coordinators, principal investigators, regulatory professionals, and quality assurance teams , this book equips you with the knowledge and tools to navigate FDA inspections confidently and successfully ensure compliance, protect human subjects, and uphold data integrity.